Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Abcellera, Beigene, Betta, Cytodyn, Eisai, Eli Lilly, Exithera, Gtreebnt, Johnson & Johnson, Junshi, Kintor, Lee's, Moderna, Nicox, Oblato, Ocumension, RDIF, Shanghai Junshi, Sorrento, Turnsole, Wellmarker.